Liposome composition
US11071713B2 · kind B2 · utility
3Cited by
12References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2020 |
| Grant date | Jul 27, 2021 |
| Priority date | — |
| Expiry date | Oct 9, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a novel liposome composition containing eribulin or its pharmacologically permissible salt, and its method of manufacture.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.